Speaker illustration

Doctor Jarl Emanuel Strange

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Member of:

European Society of Cardiology

End of life after transcatheter aortic valve implantation

Event: ESC Congress 2023

Topic: Aortic Valve Intervention

Session: Transcatheter aortic valve implantation topical challenges

Thumbnail

High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

Event: ESC Congress 2023

Topic: Aortic Valve Intervention

Session: TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Thumbnail

Readmission after transcatheter aortic valve implantation according to frailty

Event: ESC Congress 2022

Topic: Aortic Valve Intervention

Session: Transcatheter aortic valve implantation: the intangibles

Thumbnail

Oral fluoroquinolones and risk of aortic dissection and aortic aneurysm: a nationwide nested case-control study

Event: ESC Congress 2022

Topic: Cardiotoxicity of Drugs

Session: Drug cardiotoxicity: what do we need to know?

Thumbnail

Risk of heart failure following short-term non-steroidal anti-inflammatory drug use in patients with type 2 diabetes mellitus

Event: ESC Congress 2022

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic heart failure and diabetes

Thumbnail

Temporal trends in utilization of transcatheter aortic valve implantation and patient characteristics - a nationwide cohort study

Event: ESC Congress 2020

Topic: Aortic Valve Intervention

Session: Interventional Cardiology ePosters

Thumbnail

Dabigatran versus vitamin K antagonists in patients with atrial fibrillation and valvular heart disease

Event: ESC Congress 2019

Topic: Stroke Prevention

Session: Atrial fibrillation and oral anticoagulation 6

Thumbnail

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Event: ESC Congress 2018

Topic: Anticoagulants

Session: Oral anticoagulants : news from large trials and registries

Thumbnail